Associate Professor Brian McCaughan

Clinical Associate Professor
Surgery, Central Clinical School

Telephone +61 2 9550 1933
Fax +61 2 9550 6669

Map

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Linton, A., Cheng, Y., Griggs, K., Kirschner, M., Gattani, S., Srikaran, S., Kao, S., McCaughan, B., Klebe, S., van Zandwijk, N., Reid, G. (2014). An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma. British Journal of Cancer, 110(2), 510-519. [More Information]
  • Yip, P., Cooper, W., Kohonen-Corish, M., Lin, B., McCaughan, B., Boyer, M., Kench, J., Horvath, L. (2014). Phosphorylated Akt expression is a prognostic marker in early-stage non-small cell lung cancer. Journal of Clinical Pathology, 67(4), 333-340. [More Information]
  • Cooper, W., Yu, B., Yip, P., Ng, C., Lum, T., Farzin, M., Trent, R., Mercorella, B., Clarkson, A., Kohonen-Corish, M., Horvath, L., Kench, J., McCaughan, B., Gill, A., O'Toole, S. (2013). EGFR mutant-specific immunohistochemistry has high specificity and sensitivity for detecting targeted activating EGFR mutations in lung adenocarcinoma. Journal of Clinical Pathology, 66(9), 744-748. [More Information]
  • Tran, T., Selinger, C., Kohonen-Corish, M., McCaughan, B., Kennedy, C., O'Toole, S., Cooper, W. (2013). Fibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancer. Lung Cancer, 81(3), 462-467. [More Information]
  • Yip, P., Yu, B., Cooper, W., Selinger, C., Ng, C., Kennedy, C., Kohonen-Corish, M., McCaughan, B., Trent, R., Boyer, M., Kench, J., Horvath, L., O'Toole, S. (2013). Patterns of DNA mutations and ALK Rearrangement in Resected Node Negative Lung Adenocarcinoma. Journal of Thoracic Oncology, 8(4), 408-414. [More Information]
  • Cheng, Y., Kirschner, M., Cheng, N., Gattani, S., Klebe, S., Edelman, J., Vallely, M., McCaughan, B., Jin, H., van Zandwijk, N., Reid, G. (2013). ZIC1 Is Silenced and Has Tumor Suppressor Function in Malignant Pleural Mesothelioma. Journal of Thoracic Oncology, 8(10), 1317-1328. [More Information]
  • Kao, S., Armstrong, N., Condon, B., Griggs, K., McCaughan, B., Maltby, S., Wilson, A., Henderson, D., Klebe, S. (2012). Aquaporin 1 is an Independent Prognostic Factor in Pleural Malignant Mesothelioma. Cancer, 118(11), 2952-2961. [More Information]
  • Boyer, M., McCaughan, B., Barnes, D., Yip, P. (2012). Diagnosis and treatment of lung cancer: A focus on the GPs role. Medicine Today, 13(2), 30-36.
  • Kirschner, M., Cheng, V., Badrian, B., Kao, S., Creaney, J., Edelman, J., Armstrong, N., Vallely, M., Musk, A., Robinson, B., McCaughan, B., van Zandwijk, N., Reid, G., et al (2012). Increased Circulating miR-625-3p: A Potential Biomarker for Patients With Malignant Pleural Mesothelioma. Journal of Thoracic Oncology, 7(7), 1184-1191. [More Information]
  • Poursoltana, P., Currey, N., Pangon, L., van Kralingen, C., Selinger, C., Mahar, A., Cooper, W., Kennedy, C., McCaughan, B., Trent, R., et al (2012). Loss of heterozygosity of the Mutated in Colorectal Cancer gene is not associated with promoter methylation in non-small cell lung cancer. Lung Cancer, 77(2), 272-276. [More Information]
  • Chua, T., Scolyer, R., Kennedy, C., Yan, T., McCaughan, B., Thompson, J. (2012). Surgical Management of Melanoma Lung Metastasis: An Analysis of Survival Outcomes in 292 Consecutive Patients. Annals of Surgical Oncology, 19(6), 1774-1781. [More Information]
  • Cao, C., Yan, T., Kennedy, C., Hendel, N., Bannon, P., McCaughan, B. (2011). Bronchopulmonary Carcinoid Tumors: Long-Term Outcomes After Resection. The Annals of Thoracic Surgery, 91(2), 339-343. [More Information]
  • Yan, T., Cao, C., Boyer, M., Tin, M., Kennedy, C., McLean, J., Bannon, P., McCaughan, B. (2011). Improving survival results after surgical management of malignant pleural mesothelioma: an Australian institution experience. Annals of Thoracic and Cardiovascular Surgery, 17(3), 243-249. [More Information]
  • Haghshenasskashani, A., Rahnavardi, M., Yan, T., McCaughan, B. (2011). Intrathoracic application of a vacuum-assisted closure device in managing pleural space infection after lung resection: Is it an option? Interactive CardioVascular and Thoracic Surgery, 13(2), 168-174. [More Information]
  • Selinger, C., Cooper, W., Al-Sohaily, S., Mladenova, D., Pangon, L., Kennedy, C., McCaughan, B., Stirzaker, C., Kohonen-Corish, M. (2011). Loss of Special AT-Rich Binding Protein 1 Expression is a Marker of Poor Survival in Lung Cancer. Journal of Thoracic Oncology, 6(7), 1179-1189. [More Information]
  • Kao, S., Klebe, S., Henderson, D., Reid, G., Chatfield, M., Armstrong, N., Yan, T., Vardy, J., Clarke, S., van Zandwijk, N., McCaughan, B. (2011). Low Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural Pneumonectomy. Journal of Thoracic Oncology, 6(11), 1923-1929. [More Information]
  • Robinson, B., Kennedy, C., McLean, J., McCaughan, B. (2011). Node-Negative Non-small Cell Lung Cancer: Pathological Staging and Survival in 1765 Consecutive Cases. Journal of Thoracic Oncology, 6(10), 1691-1696. [More Information]
  • Poh, C., Yan, T., Vallely, M., Bannon, P., McCaughan, B. (2011). Pulmonary parenchymal endometriosis presenting as bilateral pneumothoraces. Journal of Obstetrics and Gynaecology, 31(5), 452-453. [More Information]
  • Cao, C., Andvik, S., Yan, T., Kennedy, C., Bannon, P., McCaughan, B. (2011). Staging of patients after extrapleural pneumonectomy for malignant pleural mesothelioma - institutional review and current update. Interactive CardioVascular and Thoracic Surgery, 12(5), 754-757. [More Information]
  • Cao, C., Yan, T., Bannon, P., McCaughan, B. (2011). Summary of Prognostic Factors and Patient Selection for Extrapleural Pneumonectomy in the Treatment of Malignant Pleural Mesothelioma. Annals of Surgical Oncology, 18(10), 2973-2979. [More Information]
  • Weder, W., Stahel, R., Baas, P., Dafni, U., de Perrot, M., McCaughan, B., Nakano, T., Robinson, B., van Zandwijk, N., et al (2011). The MARS feasibility trial: conclusions not supported by data. The Lancet Oncology, 12(12), 1093-1094. [More Information]
  • Kao, S., Griggs, K., Lee, K., Armstrong, N., Clarke, S., Vardy, J., van Zandwijk, N., Burn, J., McCaughan, B., Henderson, D., et al (2011). Validation of a minimal panel of antibodies for the diagnosis of malignant pleural mesothelioma. Pathology, 43(4), 313-317. [More Information]
  • Kao, S., Lee, K., Armstrong, N., Clarke, S., Vardy, J., van Zandwijk, N., Reid, G., Burn, J., McCaughan, B., Henderson, D., et al (2011). Validation of tissue microarray technology in malignant pleural mesothelioma. Pathology, 43(2), 128-132. [More Information]
  • Kao, S., McCaughan, B., Muljono, A., Boyer, M. (2010). A pathological complete response in malignant pleural mesothelioma after combination chemotherapy with Carboplatin and pemetrexed. Journal of Thoracic Oncology, 5(3), 405-406. [More Information]
  • Cao, C., Yan, T., Bannon, P., McCaughan, B. (2010). A Systematic Review of Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma. Journal of Thoracic Oncology, 5(10), 1692-1703. [More Information]
  • Lim, C., Stanford, D., Young, I., McCaughan, B., Cooper, W. (2010). Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: a report of two cases. Pathology international, 60(7), 538-541. [More Information]
  • Cooper, W., Kohonen-Corish, M., McCaughan, B., Kennedy, C., Sutherland, R., Lee, C. (2009). Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer. Histopathology, 55(1), 28-36. [More Information]
  • Yan, T., Boyer, M., Tin, M., Wong, D., Kennedy, C., McLean, J., Bannon, P., McCaughan, B. (2009). Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors. The Journal of Thoracic and Cardiovascular Surgery, 138(3), 619-624. [More Information]
  • Kao, S., Mahon, K., Rutland, J., Pawsey, C., McCaughan, B., Beale, P. (2009). Pleural well-differentiated papillary mesothelioma: a case report. Journal of Thoracic Oncology, 4(7), 920-922. [More Information]
  • Yan, T., Boyer, M., Tin, M., Sim, J., Kennedy, C., McLean, J., Bannon, P., McCaughan, B. (2009). Prognostic features of long-term survivors after surgical management of malignant pleural mesothelioma. The Annals of Thoracic Surgery, 87(5), 1552-1556. [More Information]
  • Yan, T., Black, D., Bannon, P., McCaughan, B. (2009). Systematic Review and Meta-Analysis of Randomized and Nonrandomized Trials on Safety and Efficacy of Video-Assisted Thoracic Surgery Lobectomy for Early-Stage Non–Small-Cell Lung Cancer. Journal of Clinical Oncology, 27(15), 2553-2562. [More Information]
  • Yan, T., Tin, M., McLean, J., Bannon, P., McCaughan, B. (2009). Treatment Failure after Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma. Journal of Thoracic Disease, 1(1), 23-28.
  • Maclellan, D., Cregan, P., McCaughan, B., O'Connell, T., McGrath, K. (2008). Applying clinical process redesign methods to planned arrivals in New South Wales hospitals. Medical Journal of Australia, 188(6), S23-6. [More Information]
  • Seng, T., Currey, N., Cooper, W., Lee, C., Chan, C., Sutherland, R., Horvath, L., Kennedy, C., McCaughan, B., Kohonen-Corish, M. (2008). DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma. British Journal of Cancer, 99(2), 375-382. [More Information]
  • O'Connell, T., Ben-Tovim, D., McCaughan, B., Szwarcbord, M., McGrath, K. (2008). Health services under siege: the case for clinical process redesign. Medical Journal of Australia, 188(6), S9-13. [More Information]
  • Cooper, W., Kohonen-Corish, M., Chan, C., Kwun, S., McCaughan, B., Kennedy, C., Sutherland, R., Lee, C. (2008). Prognostic significance of DNA repair proteins MLH1, MSH2 and MGMT expression in non-small-cell lung cancer and precursor lesions. Histopathology, 52(5), 613-622. [More Information]
  • Kenny, P., King, M., Viney, R., Boyer, M., Pollicino, C., McLean, J., Fulham, M., McCaughan, B. (2008). Quality of life and survival in the 2 years after surgery for non-small-cell lung cancer. Journal of Clinical Oncology, 26(2), 233-241. [More Information]
  • Cooper, W., Kohonen-Corish, M., Zhuang, L., McCaughan, B., Kennedy, C., Screaton, G., Sutherland, R., Lee, C. (2008). Role and prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand death receptor DR5 in nonsmall-cell lung cancer and precursor lesions. Cancer, 113(1), 135-142. [More Information]
  • Modi, D., Fulham, M., Mohamed, A., McCaughan, B. (2005). Intraluminal FDG uptake in a rectal polyp detected with PET CT: identification of an unsuspected synchronous primary bowel tumor. Clinical Nuclear Medicine, 30(3), 180-181. [More Information]
  • de Wilt, J., Farmer, S., Scolyer, R., McCaughan, B., Thompson, J. (2005). Isolated melanoma in the lung where there is no known primary site: metastatic disease or primary lung tumour? Melanoma Research: a journal for basic, translational and clinical research in melanoma, 15(6), 531-537. [More Information]
  • Viney, R., Boyer, M., King, M., Kenny, P., Pollicino, C., McLean, J., McCaughan, B., Fulham, M. (2004). Randomized Controlled Trial Of The Role Of Positron Emission Tomography In The Management Of Stage I And Ii Non-Small-Cell Lung Cancer. Journal of Clinical Oncology, 22(12), 2357-2362.
  • Horvath, L., McCaughan, B., Stockler, M., Boyer, M. (2002). Resection of residual pulmonary masses after chemotherapy in patients with metastatic non-seminomatous germ cell tumours. Internal Medicine Journal, 32(3), 79-83.
  • Moore, K., McCaughan, B. (2001). Surgical resection for pulmonary metastases from colorectal cancer. ANZ Journal of Surgery, 71, 143-146.
  • Moore, K., McKenzie, P., Kennedy, C., McCaughan, B. (2001). Thymoma: Trends over time. The Annals of Thoracic Surgery, 11, 203-207.

2014

  • Linton, A., Cheng, Y., Griggs, K., Kirschner, M., Gattani, S., Srikaran, S., Kao, S., McCaughan, B., Klebe, S., van Zandwijk, N., Reid, G. (2014). An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma. British Journal of Cancer, 110(2), 510-519. [More Information]
  • Yip, P., Cooper, W., Kohonen-Corish, M., Lin, B., McCaughan, B., Boyer, M., Kench, J., Horvath, L. (2014). Phosphorylated Akt expression is a prognostic marker in early-stage non-small cell lung cancer. Journal of Clinical Pathology, 67(4), 333-340. [More Information]

2013

  • Cooper, W., Yu, B., Yip, P., Ng, C., Lum, T., Farzin, M., Trent, R., Mercorella, B., Clarkson, A., Kohonen-Corish, M., Horvath, L., Kench, J., McCaughan, B., Gill, A., O'Toole, S. (2013). EGFR mutant-specific immunohistochemistry has high specificity and sensitivity for detecting targeted activating EGFR mutations in lung adenocarcinoma. Journal of Clinical Pathology, 66(9), 744-748. [More Information]
  • Tran, T., Selinger, C., Kohonen-Corish, M., McCaughan, B., Kennedy, C., O'Toole, S., Cooper, W. (2013). Fibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancer. Lung Cancer, 81(3), 462-467. [More Information]
  • Yip, P., Yu, B., Cooper, W., Selinger, C., Ng, C., Kennedy, C., Kohonen-Corish, M., McCaughan, B., Trent, R., Boyer, M., Kench, J., Horvath, L., O'Toole, S. (2013). Patterns of DNA mutations and ALK Rearrangement in Resected Node Negative Lung Adenocarcinoma. Journal of Thoracic Oncology, 8(4), 408-414. [More Information]
  • Cheng, Y., Kirschner, M., Cheng, N., Gattani, S., Klebe, S., Edelman, J., Vallely, M., McCaughan, B., Jin, H., van Zandwijk, N., Reid, G. (2013). ZIC1 Is Silenced and Has Tumor Suppressor Function in Malignant Pleural Mesothelioma. Journal of Thoracic Oncology, 8(10), 1317-1328. [More Information]

2012

  • Kao, S., Armstrong, N., Condon, B., Griggs, K., McCaughan, B., Maltby, S., Wilson, A., Henderson, D., Klebe, S. (2012). Aquaporin 1 is an Independent Prognostic Factor in Pleural Malignant Mesothelioma. Cancer, 118(11), 2952-2961. [More Information]
  • Boyer, M., McCaughan, B., Barnes, D., Yip, P. (2012). Diagnosis and treatment of lung cancer: A focus on the GPs role. Medicine Today, 13(2), 30-36.
  • Kirschner, M., Cheng, V., Badrian, B., Kao, S., Creaney, J., Edelman, J., Armstrong, N., Vallely, M., Musk, A., Robinson, B., McCaughan, B., van Zandwijk, N., Reid, G., et al (2012). Increased Circulating miR-625-3p: A Potential Biomarker for Patients With Malignant Pleural Mesothelioma. Journal of Thoracic Oncology, 7(7), 1184-1191. [More Information]
  • Poursoltana, P., Currey, N., Pangon, L., van Kralingen, C., Selinger, C., Mahar, A., Cooper, W., Kennedy, C., McCaughan, B., Trent, R., et al (2012). Loss of heterozygosity of the Mutated in Colorectal Cancer gene is not associated with promoter methylation in non-small cell lung cancer. Lung Cancer, 77(2), 272-276. [More Information]
  • Chua, T., Scolyer, R., Kennedy, C., Yan, T., McCaughan, B., Thompson, J. (2012). Surgical Management of Melanoma Lung Metastasis: An Analysis of Survival Outcomes in 292 Consecutive Patients. Annals of Surgical Oncology, 19(6), 1774-1781. [More Information]

2011

  • Cao, C., Yan, T., Kennedy, C., Hendel, N., Bannon, P., McCaughan, B. (2011). Bronchopulmonary Carcinoid Tumors: Long-Term Outcomes After Resection. The Annals of Thoracic Surgery, 91(2), 339-343. [More Information]
  • Yan, T., Cao, C., Boyer, M., Tin, M., Kennedy, C., McLean, J., Bannon, P., McCaughan, B. (2011). Improving survival results after surgical management of malignant pleural mesothelioma: an Australian institution experience. Annals of Thoracic and Cardiovascular Surgery, 17(3), 243-249. [More Information]
  • Haghshenasskashani, A., Rahnavardi, M., Yan, T., McCaughan, B. (2011). Intrathoracic application of a vacuum-assisted closure device in managing pleural space infection after lung resection: Is it an option? Interactive CardioVascular and Thoracic Surgery, 13(2), 168-174. [More Information]
  • Selinger, C., Cooper, W., Al-Sohaily, S., Mladenova, D., Pangon, L., Kennedy, C., McCaughan, B., Stirzaker, C., Kohonen-Corish, M. (2011). Loss of Special AT-Rich Binding Protein 1 Expression is a Marker of Poor Survival in Lung Cancer. Journal of Thoracic Oncology, 6(7), 1179-1189. [More Information]
  • Kao, S., Klebe, S., Henderson, D., Reid, G., Chatfield, M., Armstrong, N., Yan, T., Vardy, J., Clarke, S., van Zandwijk, N., McCaughan, B. (2011). Low Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural Pneumonectomy. Journal of Thoracic Oncology, 6(11), 1923-1929. [More Information]
  • Robinson, B., Kennedy, C., McLean, J., McCaughan, B. (2011). Node-Negative Non-small Cell Lung Cancer: Pathological Staging and Survival in 1765 Consecutive Cases. Journal of Thoracic Oncology, 6(10), 1691-1696. [More Information]
  • Poh, C., Yan, T., Vallely, M., Bannon, P., McCaughan, B. (2011). Pulmonary parenchymal endometriosis presenting as bilateral pneumothoraces. Journal of Obstetrics and Gynaecology, 31(5), 452-453. [More Information]
  • Cao, C., Andvik, S., Yan, T., Kennedy, C., Bannon, P., McCaughan, B. (2011). Staging of patients after extrapleural pneumonectomy for malignant pleural mesothelioma - institutional review and current update. Interactive CardioVascular and Thoracic Surgery, 12(5), 754-757. [More Information]
  • Cao, C., Yan, T., Bannon, P., McCaughan, B. (2011). Summary of Prognostic Factors and Patient Selection for Extrapleural Pneumonectomy in the Treatment of Malignant Pleural Mesothelioma. Annals of Surgical Oncology, 18(10), 2973-2979. [More Information]
  • Weder, W., Stahel, R., Baas, P., Dafni, U., de Perrot, M., McCaughan, B., Nakano, T., Robinson, B., van Zandwijk, N., et al (2011). The MARS feasibility trial: conclusions not supported by data. The Lancet Oncology, 12(12), 1093-1094. [More Information]
  • Kao, S., Griggs, K., Lee, K., Armstrong, N., Clarke, S., Vardy, J., van Zandwijk, N., Burn, J., McCaughan, B., Henderson, D., et al (2011). Validation of a minimal panel of antibodies for the diagnosis of malignant pleural mesothelioma. Pathology, 43(4), 313-317. [More Information]
  • Kao, S., Lee, K., Armstrong, N., Clarke, S., Vardy, J., van Zandwijk, N., Reid, G., Burn, J., McCaughan, B., Henderson, D., et al (2011). Validation of tissue microarray technology in malignant pleural mesothelioma. Pathology, 43(2), 128-132. [More Information]

2010

  • Kao, S., McCaughan, B., Muljono, A., Boyer, M. (2010). A pathological complete response in malignant pleural mesothelioma after combination chemotherapy with Carboplatin and pemetrexed. Journal of Thoracic Oncology, 5(3), 405-406. [More Information]
  • Cao, C., Yan, T., Bannon, P., McCaughan, B. (2010). A Systematic Review of Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma. Journal of Thoracic Oncology, 5(10), 1692-1703. [More Information]
  • Lim, C., Stanford, D., Young, I., McCaughan, B., Cooper, W. (2010). Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: a report of two cases. Pathology international, 60(7), 538-541. [More Information]

2009

  • Cooper, W., Kohonen-Corish, M., McCaughan, B., Kennedy, C., Sutherland, R., Lee, C. (2009). Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer. Histopathology, 55(1), 28-36. [More Information]
  • Yan, T., Boyer, M., Tin, M., Wong, D., Kennedy, C., McLean, J., Bannon, P., McCaughan, B. (2009). Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors. The Journal of Thoracic and Cardiovascular Surgery, 138(3), 619-624. [More Information]
  • Kao, S., Mahon, K., Rutland, J., Pawsey, C., McCaughan, B., Beale, P. (2009). Pleural well-differentiated papillary mesothelioma: a case report. Journal of Thoracic Oncology, 4(7), 920-922. [More Information]
  • Yan, T., Boyer, M., Tin, M., Sim, J., Kennedy, C., McLean, J., Bannon, P., McCaughan, B. (2009). Prognostic features of long-term survivors after surgical management of malignant pleural mesothelioma. The Annals of Thoracic Surgery, 87(5), 1552-1556. [More Information]
  • Yan, T., Black, D., Bannon, P., McCaughan, B. (2009). Systematic Review and Meta-Analysis of Randomized and Nonrandomized Trials on Safety and Efficacy of Video-Assisted Thoracic Surgery Lobectomy for Early-Stage Non–Small-Cell Lung Cancer. Journal of Clinical Oncology, 27(15), 2553-2562. [More Information]
  • Yan, T., Tin, M., McLean, J., Bannon, P., McCaughan, B. (2009). Treatment Failure after Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma. Journal of Thoracic Disease, 1(1), 23-28.

2008

  • Maclellan, D., Cregan, P., McCaughan, B., O'Connell, T., McGrath, K. (2008). Applying clinical process redesign methods to planned arrivals in New South Wales hospitals. Medical Journal of Australia, 188(6), S23-6. [More Information]
  • Seng, T., Currey, N., Cooper, W., Lee, C., Chan, C., Sutherland, R., Horvath, L., Kennedy, C., McCaughan, B., Kohonen-Corish, M. (2008). DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma. British Journal of Cancer, 99(2), 375-382. [More Information]
  • O'Connell, T., Ben-Tovim, D., McCaughan, B., Szwarcbord, M., McGrath, K. (2008). Health services under siege: the case for clinical process redesign. Medical Journal of Australia, 188(6), S9-13. [More Information]
  • Cooper, W., Kohonen-Corish, M., Chan, C., Kwun, S., McCaughan, B., Kennedy, C., Sutherland, R., Lee, C. (2008). Prognostic significance of DNA repair proteins MLH1, MSH2 and MGMT expression in non-small-cell lung cancer and precursor lesions. Histopathology, 52(5), 613-622. [More Information]
  • Kenny, P., King, M., Viney, R., Boyer, M., Pollicino, C., McLean, J., Fulham, M., McCaughan, B. (2008). Quality of life and survival in the 2 years after surgery for non-small-cell lung cancer. Journal of Clinical Oncology, 26(2), 233-241. [More Information]
  • Cooper, W., Kohonen-Corish, M., Zhuang, L., McCaughan, B., Kennedy, C., Screaton, G., Sutherland, R., Lee, C. (2008). Role and prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand death receptor DR5 in nonsmall-cell lung cancer and precursor lesions. Cancer, 113(1), 135-142. [More Information]

2005

  • Modi, D., Fulham, M., Mohamed, A., McCaughan, B. (2005). Intraluminal FDG uptake in a rectal polyp detected with PET CT: identification of an unsuspected synchronous primary bowel tumor. Clinical Nuclear Medicine, 30(3), 180-181. [More Information]
  • de Wilt, J., Farmer, S., Scolyer, R., McCaughan, B., Thompson, J. (2005). Isolated melanoma in the lung where there is no known primary site: metastatic disease or primary lung tumour? Melanoma Research: a journal for basic, translational and clinical research in melanoma, 15(6), 531-537. [More Information]

2004

  • Viney, R., Boyer, M., King, M., Kenny, P., Pollicino, C., McLean, J., McCaughan, B., Fulham, M. (2004). Randomized Controlled Trial Of The Role Of Positron Emission Tomography In The Management Of Stage I And Ii Non-Small-Cell Lung Cancer. Journal of Clinical Oncology, 22(12), 2357-2362.

2002

  • Horvath, L., McCaughan, B., Stockler, M., Boyer, M. (2002). Resection of residual pulmonary masses after chemotherapy in patients with metastatic non-seminomatous germ cell tumours. Internal Medicine Journal, 32(3), 79-83.

2001

  • Moore, K., McCaughan, B. (2001). Surgical resection for pulmonary metastases from colorectal cancer. ANZ Journal of Surgery, 71, 143-146.
  • Moore, K., McKenzie, P., Kennedy, C., McCaughan, B. (2001). Thymoma: Trends over time. The Annals of Thoracic Surgery, 11, 203-207.

To update your profile click here. For support on your academic profile contact .